Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

LabioTech

July 4, 2016

“We have one of the World’s Most Advanced Functional HIV Cures under development”

Reuters

April 19, 2016

Abivax gets clearance in Spain for second phase IIa trial in HIV/AIDS patients

BioCentury

March 7, 2016

ABX464: Additional Phase IIa data

Reuters

February 29, 2016

Abivax updates on ABX464 study to treat HIV

Scrip

February 10, 2016

Video Interview: Armed With Promising Clinical Data, Abivax Seeks Partners

  • 1
  • …
  • 43
  • 44
  • 45
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn